Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 5
2005 4
2006 5
2007 5
2008 6
2009 6
2010 4
2011 5
2012 7
2013 9
2014 7
2015 11
2016 11
2017 8
2018 11
2019 20
2020 19
2021 15
2022 12
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Results by year

Filters applied: . Clear all
Page 1
Wiskott-Aldrich syndrome.
Kariya S, Nishizaki K, Paparella MM, Cureoglu S. Kariya S, et al. Otol Neurotol. 2013 Apr;34(3):e16-7. doi: 10.1097/MAO.0b013e31827de304. Otol Neurotol. 2013. PMID: 23370560 No abstract available.
Rosai-Dorfman disease with extranodal involvement.
Hashimoto K, Kariya S, Onoda T, Ooue T, Yamashita Y, Naka K, Okano M, Nishizaki K. Hashimoto K, et al. Among authors: kariya s. Laryngoscope. 2014 Mar;124(3):701-4. doi: 10.1002/lary.24290. Epub 2013 Jul 29. Laryngoscope. 2014. PMID: 23818241 Review.
Panel 1: Biotechnology, biomedical engineering and new models of otitis media.
Gisselsson-Solén M, Tähtinen PA, Ryan AF, Mulay A, Kariya S, Schilder AGM, Valdez TA, Brown S, Nolan RM, Hermansson A, van Ingen G, Marom T. Gisselsson-Solén M, et al. Among authors: kariya s. Int J Pediatr Otorhinolaryngol. 2020 Mar;130 Suppl 1(Suppl 1):109833. doi: 10.1016/j.ijporl.2019.109833. Epub 2019 Dec 27. Int J Pediatr Otorhinolaryngol. 2020. PMID: 31901291 Free PMC article. Review.
Efficacy and safety of 1.5% levofloxacin otic solution for the treatment of otitis media in a multicenter, randomized, double-blind, parallel-group, placebo-controlled, phase III study.
Takahashi M, Iwasaki S, Kawano T, Ikoma R, Oka S, Terasaki M, Sato H, Kariya S, Takahashi H. Takahashi M, et al. Among authors: kariya s. Auris Nasus Larynx. 2023 Aug;50(4):521-533. doi: 10.1016/j.anl.2022.12.013. Epub 2023 Jan 3. Auris Nasus Larynx. 2023. PMID: 36599786 Free article. Clinical Trial.
Labyrinthitis ossificans following severe acute otitis media.
Uraguchi K, Kariya S, Ando M. Uraguchi K, et al. Among authors: kariya s. Clin Case Rep. 2022 May 24;10(5):e05898. doi: 10.1002/ccr3.5898. eCollection 2022 May. Clin Case Rep. 2022. PMID: 35646348 Free PMC article.
IgG4 Expression in Patients with Eosinophilic Otitis Media.
Takahashi M, Oka A, Kariya S, Gion Y, Sato Y, Iwasaki S, Oyamada S, Matsubara A, Okano M. Takahashi M, et al. Among authors: kariya s. ORL J Otorhinolaryngol Relat Spec. 2021;83(3):167-171. doi: 10.1159/000512726. Epub 2021 Mar 10. ORL J Otorhinolaryngol Relat Spec. 2021. PMID: 33691317
147 results